Fact CheckerSign in

NCT07224191Recruiting

Hippocampal Oscillations During Exploration

Human Hippocampal Oscillations During Visuomotor Exploration

Source: ClinicalTrials.gov · Last updated 8 Jul 2026

Brief summary (registry, in English)

The objective of this study is to determine how visuomotor exploration relates to hippocampal activity along its long axis. The study will investigate the neurophysiological mechanisms in the hippocampus during (1) visual exploration in surgical patients using high-resolution iEEG, and (2) ambulatory exploration in patients implanted with RNS devices.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
56 (estimated)
First submitted
31 Oct 2025
Start date
25 Feb 2026
Primary completion date
8 Oct 2028
Lead sponsor
NYU Langone Health
Diseases
Epilepsy
NCT number
NCT07224191

What you commit to

  • Study type: Interventional
  • Planned participants: 56
  • From 25 Feb 2026 to the primary completion date, 8 Oct 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Smoking tobacco, marijuana, recreational drugs or alcohol use within 1 week of cognitive testing

Other illness

  • Any generalized tonic-clonic seizure within the last week
    • All subjects:

Other

  • RNS patients, Aim 2:
  • Legally blind
  • Unable to give informed consent
  • Pregnancy

Who the study is looking for

  • All subjects:
  • Adults (18-70 years)
  • Able to provide informed consent
    • Aim 1: Surgical epilepsy patients' inclusion criteria
  • Implanted hippocampal depth electrodes for Stage 1 epilepsy surgery
  • MMSE\>=24
    • Aim 2: RNS patients Inclusion criteria
  • Implanted RNS device with at least one hippocampal depth electrode
  • At least 5 months post-implantation to avoid the post-implant effect
  • Have a relatively low number of seizures, defined as \<1 generalized tonic-clonic or other seizure with potential to fall or cause injury per month
  • Able to walk and wear research equipment without assistance
  • MMSE\>=24
    • Aim 2: Healthy Control Inclusion criteria • Able to walk and wear research equipment without assistance

Age in the registry: 18 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
NYU Langone Health
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.